CLSI eNews - 1 August 2007  (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.
 
News
 Executive Vice President's Message
 CLSI President-Elect to Meet With JCCLS in Tokyo
 CLSI's The Key to Quality
 Lois Schmidt, DA Appointed CLSI’s Vice President of Standards
 James Nichols, PhD, DABCC, FACB To Serve as CLSI’s Editorial Review Board Representative for Lab Tests Online
 Honoring the Life and Accomplishments of Richard R. Miller, Jr.
 Recent Changes to CLSI Membership Categories
 Press Releases
Standards Status
 Vote and Deadlines
 Recently Approved Documents
 Recently Distributed ISO Standard
 Call for Nominations
Events and Exhibits
 Upcoming Events
 Upcoming Presentations
 CLSI Meetings Calendar
Participate in CLSI
 Volunteer
 New and Sustaining Members
 Update Your Subscription


Vote and Deadlines

Analytical Procedures for the Determination of Lead in Blood and Urine (C40-A); Laboratory Instrument Implementation, Verification, and Maintenance (GP31-P); Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture (H3-A6); Protocol for the Evaluation, Validation, and Implementation of Coagulometers (H57-P); Platelet Function Testing by Aggregometry (H58-P); Verification and Validation of Multiplex Nucleic Acid Assays (MM17-P)

CLSI submits the following for vote as a candidate-for-advancement consensus documents.  The documents and ballots are available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums.  

MM17-PVerification and Validation of Multiplex Nucleic Acid Assays
This guideline provides recommendations for analytic verification and validation of multiplex assays, as well as a review of different types of biologic and synthetic reference materials. The deadline for the completed ballot for MM17-P to be received at the CLSI offices is 28 September 2007.

Second Notice

C40-AAnalytical Procedures for the Determination of Lead in Blood and Urine; Approved Guideline
This document offers guidance for the measurement of lead in blood and urine, including specimen collection, measurement by GFAAS and ASV, quality assurance, and quality control. The deadline for the completed ballot for C40-A to be received at the CLSI offices is 28 August 2007.

GP31-PLaboratory Instrument Implementation, Verification, and Maintenance; Proposed Guideline
This guideline provides information about assessing instrument performance and function from the time of instrument purchase to the routine performance of clinical testing. A CLSI-CAP joint project. The deadline for the completed ballot for GP31-P to be received at the CLSI offices is 6 August 2007.

H3-A6Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard – Sixth Edition
This document provides procedures for the collection of diagnostic specimens by venipuncture, including line draws, blood culture collection, and venipuncture in children. It also includes recommendations on order of draw. The deadline for the completed ballot for H3-A6 to be received at the CLSI offices is 13 August 2007.

H57-PProtocol for the Evaluation, Validation, and Implementation of Coagulometers; Proposed Guideline
This document provides guidance and procedures to the end -user and manufacturer for the selection, evaluation, validation, and implementation of a laboratory coagulometer. The deadline for the completed ballot for H57-P to be received at the CLSI offices is 28 August 2007.

H58-PPlatelet Function Testing by Aggregometry; Proposed Guideline
This document provides concrete, standard procedures for using aggregometry to assess platelet function in patient specimens with the intent to achieve greater uniformity of results. The deadline for the completed ballot for H58-P to be received at the CLSI offices is 28 August 2007.


Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership.


For more information or to contact us directly, please visit www.clsi.org l ©2006 Clinical and Laboratory Standards Institute